Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases
Maria J. Sambade(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University), Andrew D. Seidman(Memorial Sloan Kettering Cancer Center), Adam Brufsky(University of Pittsburgh), Stergios J. Moschos(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Aki Morikawa(Memorial Sloan Kettering Cancer Center), José Pablo Leone(Harvard University), Megan Jean McKee(University of North Carolina at Chapel Hill), Allison M. Deal(Memorial Sloan Kettering Cancer Center), Dimitri G. Trembath(Johns Hopkins University), Bentley R. Midkiff(Segeberger Kliniken), Edi Brogi(Memorial Sloan Kettering Cancer Center), Juanita Ramirez(University of North Carolina at Chapel Hill), Benjamin Vincent(University of North Carolina at Chapel Hill), Matthew G. Ewend, Kevin Keith(Medical University of South Carolina), Grace Prince(University of North Carolina at Chapel Hill), Kimberly Blackwell(Duke University), Ronald L. Hamilton(University of Pittsburgh), Amy Garrett(University of North Carolina at Chapel Hill), Sarah Sammons(Dana-Farber Cancer Institute)
Cited by 23
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k